Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insulin resistance. The objective of this study is to compare fasting glucose, fasting insulin concentrations and HOMA-IR in strength of association with incident cardiovascular disease. METHODS: We searched the PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect and Cochrane Library databases from inception to March, 2011, and screened reference lists. Cohort studies or nested case-control studies that investigated the association between fasting glucose, fasting insulin or HOMA-IR and incident cardiovascular disease, were eligible. Two investigators independently performed the article selection, data extraction and risk of bias assessment. Cardiovascular endpoints were coronary heart disease (CHD), stroke or combined cardiovascular disease. We used fixed and random-effect meta-analyses to calculate the pooled relative risk for CHD, stroke and combined cardiovascular disease, comparing high to low concentrations of glucose, insulin or HOMA-IR. Study heterogeneity was calculated with the I(2) statistic. To enable a comparison between cardiovascular disease risks for glucose, insulin and HOMA-IR, we calculated pooled relative risks per increase of one standard deviation. RESULTS: We included 65 studies (involving 516,325 participants) in this meta-analysis. In a random-effect meta-analysis the pooled relative risk of CHD (95% CI; I(2)) comparing high to low concentrations was 1.52 (1.31, 1.76; 62.4%) for glucose, 1.12 (0.92, 1.37; 41.0%) for insulin and 1.64 (1.35, 2.00; 0%) for HOMA-IR. The pooled relative risk of CHD per one standard deviation increase was 1.21 (1.13, 1.30; 64.9%) for glucose, 1.04 (0.96, 1.12; 43.0%) for insulin and 1.46 (1.26, 1.69; 0.0%) for HOMA-IR. CONCLUSIONS: The relative risk of cardiovascular disease was higher for an increase of one standard deviation in HOMA-IR compared to an increase of one standard deviation in fasting glucose or fasting insulin concentration. It may be useful to add HOMA-IR to a cardiovascular risk prediction model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both prediabetes and metabolic syndrome confer increased risk of T2D and CVD.802–804”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [803]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a meta-analysis of the association between Homeostasis Model Assessment Insulin Resistance (HOMA-IR) and cardiovascular events used dose-response modelling to estimate that the cardiovascular risk increased by 46% per one standard deviation increase in HOMA-IR [24].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In observational studies, a reduction in HOMA-IR was also associated with a reduction in CRP 81 and cardiovascular risk. 82”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · cited 2×
“Finally, we only included studies that measured HOMA-IR, which is a surrogate measure of insulin resistance and mainly reflects hepatic insulin resistance [12].”
BackgroundMethodIDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Research works printed but not linked: 1
- Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Lippincott Williams & Wilkins. 112 p.
Cited by
Items 201–300 of 402
Vajdi, M., Ardekani, A. M., Nikniaz, Z., Hosseini, B., & Farhangi, M. A. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01377-4 · Cited by 10
Stähli, B. E., Nozza, A., Schrieks, I. C., Buse, J. B., Malmberg, K., Mellbin, L., Neal, B. C., Nicholls, S. J., Rydén, L., Svensson, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02772 · Cited by 13
“In that context, HOMA-IR has been shown to have incremental predictive value above glucose or insulin measurements alone (14, 27).”
BackgroundEndothelial dysfunction and inflammation in patients with non-obstructive coronary arteries
Pakhtusov, N. N., Iusupova, A. O., Privalova, E. V., Khabarova, N. V., & Belenkov, Y. N. (2021) · Kardiologiia · doi:10.18087/cardio.2021.1.n1423 · Cited by 12
Insulin resistance and cardiovascular outcomes in the ORIGIN trial
Gerstein, H. C., Ferrannini, E., Riddle, M. C., Yusuf, S., & ORIGIN Trial Investigators (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13112 · Cited by 13
“Many, but not all,(25) large prospective epidemiologic studies have reported an association between resistance to the metabolic actions of insulin and CV outcomes.(8) In these studies, insulin resistance was estimated using rather crude proxies (typically, fasting plasma insulin concentrations and the HOMA-IR model(8,…”
BackgroundPlasma proteomic signatures for type 2 diabetes and related traits in the UK Biobank cohort
Gupte, T. P., Azizi, Z., Kho, P. F., Zhou, J., Nzenkue, K., Chen, M., Panyard, D. J., Guarischi‐Sousa, R., Hilliard, A. T., Sharma, D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112194 · Cited by 13
Yang, Y., Liu, Z., Lin, B., HUANG, Y. ‐., Deng, H., Yang, X., Zeng, L., Yan, J., & Xu, W. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01732-6 · Cited by 13
“IR was linked to various chronic conditions [28] and, in certain cases, mortality [29, 30].”
β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke
Kiyohara, T., Matsuo, R., Hata, J., Nakamura, K., Wakisaka, Y., Kamouchi, M., Kitazono, T., Ago, T., Ishitsuka, T., Ibayashi, S., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031392 · Cited by 10
Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala, S., Rajan, J., Yang, E., & DeFronzo, R. A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02055-0 · Cited by 13
“In a metaanalysis of 17 large prospective studies [44], HOMA-IR (product of fasting plasma insulin and glucose concentrations) was shown to be a strong predictor of adverse cardiovascular events (HR = 1.64; 95% CI = 1.35, 2.00; p < 0.001).”
InfluentialHino, A., Inoue, A., Mafune, K., Nakagawa, T., Hayashi, T., & Hiro, H. (2016) · Journal of Occupational Health · doi:10.1539/joh.16-0061-oa · Cited by 10
The relationship between hepatic steatosis index and hypertension: NHANES 2011–2018
Zhang, W., Gao, B., Wang, Y., Cao, Y., & Wang, J. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04744-2 · Cited by 11
Курбановна, Ш. Е., Kobalava, Z. D., Ezhova, N. E., Khomova, I., & Bazdyreva, E. I. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3-3774 · Cited by 10
Bøgh, H. L., Stanislaus, S., Kjærstad, H. L., Sletved, K. S. O., Forman, J. L., Poulsen, H. E., Vinberg, M., Kessing, L. V., & Coello, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02095-6 · Cited by 10
“However, insulin resistance index, a component of the more advanced assessment of metS [16], often preceding development of type 2 diabetes and CVD [39, 40], was positively associated with 8-oxoGuo across the three participant groups, however, this association did not persist in exploratory analyses only including UR…”
BackgroundKim, H., Kim, B. S., Lee, Y., Ahn, S. B., Kim, D. W., & Shin, J. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0197 · Cited by 9
Wu, H., Chu, T.-Y., Iqbal, J., Jiang, H., Li, L., Wu, Y., & Zhou, H. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad233 · Cited by 12
Kokavec, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.022 · Cited by 11
“Clinical data has confirmed that insulin resistance is a risk factor for hypertension [30], stroke [25] and cardiovascular disease [13].”
Diabetes mellitus, glycemic traits, and cerebrovascular disease: a Mendelian randomization studyPreprint
Georgakis, M. K., Harshfield, E. L., Malik, R., Franceschini, N., Langenberg, C., Wareham, N. J., Markus, H. S., & Dichgans, M. (2019) · medRxiv · doi:10.1101/2019.12.27.19015834 · Cited by 9
Cardiovascular complications in insulin resistance and endocrine diseases
Tsuchiya, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej22-0457 · Cited by 9
Tang, L., Xiao-dong, X., Chen, M., Li, J., & Pu, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-71718-3 · Cited by 9
The association between micro- and nano-plastics and cardiovascular outcomes: a comprehensive review
Oraee, S., Alinejadfard, M., Mahdavi, S., Firouzabadi, S. R., Hatami, S., Mohammadi, I., Zarinfar, Y., & Khaheshi, I. (2025) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-025-00248-w · Cited by 11
“Insulin resistance [99], a significant predictor of heart failure [100] and cardiovascular events [101], has been observed secondary to MNP exposure.”
Hadwen, J., Kim, W., Dewar, B., Ramsay, T., Davis, A., Dowlatshahi, D. D., & Shamy, M. C. F. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044771 · Cited by 9
Monti, L. D., Genzano, C. B., Fontana, B., Galluccio, E., Spadoni, S., Magistro, A., Bosi, E., & Piatti, P. (2021) · Endocrine · doi:10.1007/s12020-021-02868-x · Cited by 7
Wen, W., Fan, H., Zhang, S., Hu, S., Chen, C., Tang, J., You, Y., Wang, C., Li, J., Luo, L., et al. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.06.022 · Cited by 12
Westergren, H. U., Michaëlsson, E., Blomster, J., Miliotis, T., Svedlund, S., & Gan, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176511 · Cited by 8
“HOMA-IR incorporates both glucose and insulin concentrations and shows stronger association with cardiovascular disease than glucose or insulin concentration alone in non-diabetic patients [14].”
BackgroundUtility of metabolic syndrome as a risk enhancing factor in decision of statin use
Vega, G. L., Wang, J., & Grundy, S. M. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.01.012 · Cited by 9
Aortic Fibrosis in Insulin-Sensitive Mice with Endothelial Cell-Specific Deletion of Ceacam1 Gene
Helal, R. A., Muturi, H. T., Lee, A. D., Li, W., Ghadieh, H. E., & Najjar, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084335 · Cited by 7
“Insulin resistance is an independent risk factor for atherosclerosis [3,6,7].”
BackgroundRethinking the role of pioglitazone in modern diabetology as a cardiorenoprotective agent
Салухов, В. В., & Анатольевна, К. Е. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-10-10-21 · Cited by 10
Asgari, S., Masrouri, S., Khalili, D., Azizi, F., & Hadaegh, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1018403 · Cited by 9
“%) for Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (35).”
MethodInfluentialYin, T., Chen, S., Zhu, Y., Kong, L., Li, Q., Zhang, G., & He, H. (2024) · Food & Function · doi:10.1039/d4fo00941j · Cited by 9
Zhang, H., Tan, X. W., & Wang, N. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.11.003 · Cited by 9
“69) for HOMAIR, which was much higher than that for glucose and fasting insulin.(18) The reason may be due to unfavorable effects of insulin resistance on endothelial dysfunction and inflammation.”
BackgroundLi, K., Li, Y., Jiang, S., Xing, W., & Zhao, L. (2026) · European journal of medical research · doi:10.1186/s40001-025-03808-5 · Cited by 14
“IR drives cardiovascular pathogenesis via increased arterial stiffness [22].”
Li, L., Cai, G., Lü, W., Li, F., Yu, L., & Xiao, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1255656 · Cited by 7
Ayanful‐Torgby, R., Shabanova, V., Essuman, A. A., Boafo, E., Aboagye, F. T., Al‐Mahroof, Y., Amponsah, J. A., Tetteh, J. K. A., Amoah, L. E., & Paintsil, E. (2024) · HIV Medicine · doi:10.1111/hiv.13614 · Cited by 7
“However, although impaired glucose metabolism in children, including insulin resistance, could be a risk or predictor of cardiovascular disease in adulthood [10, 11], diagnosing glucose impairment in children is challenging as it often presents asymptomati-cally [12].”
BackgroundRyu, H. E., Jung, D., Heo, S., Park, B., & Lee, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1346158 · Cited by 7
Relationships Between APOE, Type 2 Diabetes, and Cardiovascular Disease in Postmenopausal Women
Dunk, M. M., Driscoll, I. F., Espeland, M. A., Hayden, K. M., Liu, S., Nassir, R., Natale, G., Shadyab, A. H., & Manson, J. E. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae246 · Cited by 8
“CVD is estimated to affect 32% of T2DM patients (47), and CVD risk increases with higher fasting blood glucose levels and greater insulin resistance even in those without a history of diabetes (48,49).”
Bohara, S., Bagheri, A., Ertugral, E. G., Radzikh, I., Sandlers, Y. I., Jiang, P., & Kothapalli, C. R. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00457-w · Cited by 10
“…patients cannot maintain glucose homeostasis, it results in hyper-glycemia, hyperinsulinemia, inflammation, and higher body fat content, which in turn dysregulate the immune system, adipokines, gut microbiota, and a host of other tissue functions, resulting in arterial remodeling and CVD [8].”
BackgroundHellgren, M. I., Daka, B., Jansson, P., & Lindblad, U. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.10.009 · Cited by 10
Carrico, A. W., Rodriguez, V. J., Jones, D. L., & Kumar, M. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2645 · Cited by 7
Liang, K., Sheu, W. H., Lee, W., Lee, W.-L., Pan, H.-C., Lee, I., & Wang, J. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0209-1 · Cited by 7
“Several population-based studies have applied fasting insulin level or HOMA-IR as a marker of insulin resistance and have shown significant associations with cardiovascular events in non-diabetic individuals, independent of other risk factors [30, 31].”
MethodAdvances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus
Hu, Y. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.01.001 · Cited by 7
“Of those, 73.1% had previous CVD.”
BackgroundInfluentialKöktürk, U., Onalan, O., Somuncu, M. U., Uygur, B., Erbay, İ., Çakan, F., & Avcı, A. (2024) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2023.58554 · Cited by 11
“18 There is a well-established strong correlation between IR and increased risk of CVD. 19 Research by Bonora et al. 20 demonstrated the link between CVD and IR independent of other atherosclerosis risk factors.”
BackgroundWilkinson, M., Rollin, T., Kuriakose, M., Haggerty-Goede, R. A. L., Miller, D. M., & Dunham‐Snary, K. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110370 · Cited by 6
Lee, J. H., Lee, H. S., Jeon, S., Lee, Y., Park, B., Lee, J., & Kwon, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03615-0 · Cited by 6
Skals, R. G., Krogager, M. L., Appel, E. V. R., Schnurr, T. M., Have, C. T., Gislason, G., Poulsen, H. E., Køber, L., Engstrøm, T., Stender, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252855 · Cited by 7
Kim, H. S., Lee, J., Cho, Y. K., Kim, E. H., Lee, M. J., Kim, H., Park, J., Lee, W. J., & Jung, C. H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1184 · Cited by 5
“Insulin resistance increases the risk of metabolic syndrome, T2D, and cardiovascular diseases [10].”
Insulin resistance as a predictor of cardiovascular diseases
Domingues, N. S. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.06.004 · Cited by 6
Thomas, H. J., Marsh, C. E., Maslen, B. A., Lester, L., Naylor, L. H., & GREEN, D. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274082 · Cited by 8
“For DBP, significantly more subjects CV disease [24].”
BackgroundInfluentialManjoo, P., Dannenbaum, D. A., Joseph, L., Torrie, J., & Dasgupta, K. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000114 · Cited by 10
“Antihypertensive, N (%) 0 (0) 6 (12) 12 (18) 110 (34) 3 (7) 8 (14) 9 (19) 67 (38)”
Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling
Klén, R., Honka, M., Hannukainen, J. C., Huovinen, V., Bucci, M., Latva‐Rasku, A., Venäläinen, M. S., Kalliokoski, K. K., Virtanen, K. A., Läutamaki, R., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa026 · Cited by 6
Gómez‐Sánchez, L., Gómez‐Sánchez, M., Lugones‐Sánchez, C., Tamayo‐Morales, O., González‐Sánchez, S., Rodríguez‐Sánchez, E., García‐Ortiz, L., Gómez-Marcos, M. Á., & on behalf of the EVA Investigators (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245748 · Cited by 6
Sayın, S., Kutlu, R., & Koçak, A. (2018) · The European Research Journal · doi:10.18621/eurj.414561 · Cited by 6
“In meta-analysis studies, it was seen that increased insulin and fasting blood glucose in non-diabetic patients increase CVD risk significantly [22, 23].”
BackgroundKang, S.-J., Jo, E.-H., Yang, G.-J., Shim, Y.-H., Hong, J.-E., & Park, M.-C. (2019) · Medicine · doi:10.1097/md.0000000000015479 · Cited by 7
Alogaili, M. H., & Alsallami, A. A. (2024) · Intern J Endocrinol Metab · doi:10.5812/ijem-145894 · Cited by 6
“Insulin resistance has a tremendous impact on the pathophysiology of HTN and the subsequent development of CV diseases and complications, which are further exacerbated by the presence of lipid and glucose abnormalities (1).”
Shi, Y., Zhang, Z., Yang, J., & Cui, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1583944 · Cited by 5
“Existing studies and meta-analyses indicate that IR is signi fi cantly associated with ASCVD and serves as an effective predictor for ASCVD, showing IR as a major risk factor contributing to ASCVD through various metabolic pathways (8 – 12).”
Alexandre, M., Poínhos, R., CRI-O Group, Oliveira, B. M. P. M., & Correia, F. (2025) · Nutrients · doi:10.3390/nu17111858 · Cited by 7
“For this reason, despite ET presenting lower fasting glucose, they present higher CVD risk than MT or IT [62].”
Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer
Lee, W., Yamada, T., Liu, W.-J., Hara, K., Yamauchi, T., Yanagimoto, S., & Hiraike, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-68355-x · Cited by 7
Abushamat, L. A., Schauer, I. E., Wang, C. C. L., Mitchell, S., Herlache, L., Bridenstine, M., Durbin, R. J., Snell‐Bergeon, J. K., Regensteiner, J. G., & Reusch, J. E. B. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589231225183 · Cited by 6
“Compared to activity-and weight-matched controls, individuals with T2D have impairments in FEC in the absence of apparent CVD. 7,8 Our group and others have demonstrated specific impairments including reductions in VO 2 peak and slowed VO 2 kinetics during maximal and submaximal exercise in people with T2D.”
Jackisch, J., Noor, N., Raitakari, O. T., Lehtimäki, T. J., Kähönen, M. A. P., Cullati, S., Delpierre, C., Kivimäki, M., & Carmeli, C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078428 · Cited by 9
“Finally, based on fasting plasma glucose and insulin, we will examine (8) the homeostasis model of insulin sensitivity (HOMA), as it is used to diagnose insulin resistance, 52 which is a causal risk factor for cardiovascular diseases and type 2 diabetes.”
Phuc, P. T., Nguyen, P., Nguyen, N. N., Hsu, M., Le, N. Q. K., Tran, Q., Huang, C., Yang, H., Chen, C., Le, T. A. H., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/52107 · Cited by 8
“Its predictive skills and flexibility enable it to excel in diverse domains, such as health care [18-23].”
Ichikawa, T., Hashimoto, Y., Okamura, T., Obora, A., Kojima, T., Okada, H., Hamaguchi, M., & Fukui, M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.002 · Cited by 6
Simental‐Mendía, L. E., Sánchez‐García, A., & Guerrero‐Romero, F. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04935-z · Cited by 5
“Insulin resistance is an abnormal physiological response characterized by increased insulin secretion in order to maintain normal glucose tolerance [8], a condition that has been associated with an increased risk of developing cardiovascular disease in adults without diabetes [9].”
BackgroundLaupsa‐Borge, J., Grytten, E., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1020678 · Cited by 6
Alipoor, E., Hosseinzadeh‐Attar, M. J., Vasheghani‐Farahani, A., Salmani, M., Rezaei, M., Namkhah, Z., Ahmadpanahi, M., Jenab, Y., Alidoosti, M., & Yaseri, M. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156314 · Cited by 6
Song, Y., Lee, K., & Sung, J. (2014) · Twin Research and Human Genetics · doi:10.1017/thg.2014.23 · Cited by 5
“, 2007), cardiovascular disease (Gast et al., 2012), cancer (Tsugane & Inoue, 2010), and all-cause mortality (Ausk et al.”
InfluentialAdegoke, T. E., Sabinari, I. W., Usman, T. O., Abdulkareem, T., Michael, O. S., Adeyanju, O. A., Dibia, C., Omotoye, O. O., Oyabambi, A. O., & Olatunji, L. A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1767148 · Cited by 6
“Impaired glucose tolerance, hyperinsulinemia, dyslipidemia with elevated triglyceride level and endothelial dysfunction are well-documented risk factors for cardiovascular disease (CVD) (Calles-Escandon and Cipolla 2001, Gast et al. 2012).”
BackgroundWen, J., Liu, H., Du, X., & Ma, C. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s370118 · Cited by 5
“The cardiovascular mortality rates were 148.1, 100.4, and 106.5 per 1,000 person-years among the normal weight, overweight, and obese patients without DM, and 203.9, 210.5, and 204.7 per 1,000 person-years among the normal weight, overweight, and obese patients with DM. Association of Fasting Blood Glucose with Mortal…”
BackgroundInfluentialManagement of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Mihai, B. M., Petriş, A. O., Ungureanu, D. A., & Lăcătușu, C.-M. (2014) · Open Medicine · doi:10.1515/med-2015-0003 · Cited by 6
Li, H., Chen, S., Qian, F., Tian, X., Zuo, Y., Li, X., Guo, X., Wu, S., & Wang, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1586954/v1 · Cited by 5
Yu, L., Liu, Y., Guo, R., Yang, T., Pan, G., He, Y., Gao, S., Yang, R., Li, Z., Li, L., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1473308 · Cited by 5
The Significant Role of Physical Activity and Exercise in Health and Metabolic Diseases
Dimitriadis, G., Chryssanthopοulos, C., Philippou, Α., & Koutsilieris, M. (2025) · Physiologia · doi:10.3390/physiologia5040057 · Cited by 12
Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
Adeva‐Andany, M. M., Fernández‐Fernández, C., Adeva-Contreras, L., Carneiro-Freire, N., Domínguez-Montero, A., & Mouriño-Bayolo, D. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16999201210200012 · Cited by 5
Dai, M., Li, D., Yu, J., Liu, Y., Zhang, Q., Zhang, W., Zhong, Y., Wan, Z., Tang, M., Gao, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-92779-y · Cited by 4
“we hypothesize that IR may be a significant factor contributing to the increased risk of SMI in diabetic patients 12 and could serve as an effective indicator for the early identification of SMI.”
Schlienger, J.-L. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30021-5 · Cited by 5
Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
Harasim‐Symbor, E., Polak, A., Konstantynowicz-Nowicka, K., Bielawiec, P., Malinowska, B., Kasacka, I., & Chabowski, A. (2020) · Molecules · doi:10.3390/molecules25081932 · Cited by 4
Huang, B. X., Huang, W., Allen, J. C., Sun, L., Goh, H. J., Kong, S. C., Lee, D., Ding, C., Bosco, N., Egli, L., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.979208 · Cited by 4
“Smoker (%) 5 (12) 1 (8) 1 (7) 3 (9) 1.”
MethodMohammadparast, V., Mohammadi, T., Karimi, E., & Mallard, B. L. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00448-1 · Cited by 4
The integrated effect of moderate exercise on coronary heart disease
Mathews, M. J., Mathews, E. H., & Mathews, G. E. (2017) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2016-058 · Cited by 5
Rafi, M. S. H., Ivy, S. C., & Dewan, S. M. R. (2025) · Health Science Reports · doi:10.1002/hsr2.71376 · Cited by 6
“…these technologies are not widely accessible in LMICs, integrating biomarker screening and centralized imaging hubs into care pathways could improve early detection and management of diabetes and cardiovascular comorbidities, complementing strategies like task shifting and digital health [68].”
Sun, Z., Wang, K., Guo, C., Qiu, J., Wang, W., Xu, Y., Tang, Y., Kadier, K., Wen, S., & Zhang, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03293-y · Cited by 4
“Insulin resistance may contribute to atherosclerosis, endothelial dysfunction, vascular stiffness, and subsequent cardio-vascular events [11, 34, 35].”
Li, Y., Song, W., Huan, C., Xu, K., Sun, J., Zhen, X., Ouyang, H., Tang, H., Fan, Q., Zhi, W., et al. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109089 · Cited by 3
Is Insulin Resistance an Independent Predictor of Atherosclerosis?
Landowska, M., Kałuża, B., Watała, C. W., Babula, E., Żuk‐Łapan, A., Woźniak, K., Kargul, A., Jurek, J., Korcz, T., Małgorzata, C.-B., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030969 · Cited by 6
Song, Y., & Lee, K. (2020) · Nutrition · doi:10.1016/j.nut.2020.110939 · Cited by 3
Cardiorespiratory Fitness - New Topics
Sözen, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100928 · Cited by 4
Cardiorespiratory Benefits of Exercise
Wang, D., Qu, K., Yangm, M., Yang, X., Lu, A., & Ren, J. T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.107360 · Cited by 6
Diabetes and Cardiovascular Disorder
Priya, S. S., & Ebenezar, K. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-0027-3_3 · Cited by 3
Manaserh, I. H., Bledzka, K. M., Ampong, I., Junker, A., Grondolsky, J., & Schumacher, S. M. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.09.001 · Cited by 4
Perticone, M., Shehaj, E., Suraci, E., Andreozzi, F., & Perticone, F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03803-4 · Cited by 3
Atefi, M., Vahedi, H., Darand, M., & Entezari, M. H. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01123-0 · Cited by 4
“Similarly, a 1-unit decrease in HOMA-IR correlates with improved insulin sensitivity and reduced cardiovascular risk [60].”
Wang, Z., Fan, H., Wang, L., & Wang, T. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.2205 · Cited by 3
“Abnormal glucose tolerance is closely associated with diabetes, stroke and heart attacks (1-3).”
BackgroundCORRELATION BETWEEN INSULIN RESISTANCE AND SEVERITY OF CORONARY ARTERY DISEASE IN NON-DIABETES
Srinivasan, M. P. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i6.14637 · Cited by 3
“Similar results were also obtained by a metaanalysis, which concluded that there 46% increase in the relative risk of symptomatic CAD per 1-SD increment in HOMA-IR [28].”
ResultImportance of high triglycerides levels between novel coronary risk factors
Bermúdez, V., Salazar, J. J., Calvo, M. G., Martínez, M. S., Áñez, R., Rivas-Ríos, J. R., Chacín, M., Hernández-Lalinde, J., Graterol, M., & Rojas, J. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2017.03.001 · Cited by 3
Role of insulin action in the pathogenesis of diabetic complications
Tsuchiya, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00601-1 · Cited by 3
“Interestingly, a strong correlation has been established between insulin resistance and the risk of developing cardiovascular diseases (CVDs) [9].”
BackgroundInsulin resistance as a predictor of cardiovascular diseases
Domingues, N. S. (2021) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2021.07.025 · Cited by 3
Zhang, X., Min, R., Wang, Z., Qi, Y., Li, R., & Fan, J. (2024) · Phytotherapy Research · doi:10.1002/ptr.8339 · Cited by 4
Aziz, S., Wani, J. I., Alqahtani, S. A. M., Durrani, H. K., Jehangir, A., Elkenany, N. M., Sabah, Z. U., Patel, A. A., Alfayea, M. A., & Ali, N. M. T. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01865-8 · Cited by 2
“A meta-analysis involving 65 trials demonstrated a 46% increase in the likelihood of developing CAD for each standard deviation (SD) increase in IR among non-diabetic individuals [11].”
Gestational Diabetes Mellitus and Future Risk of Cardiovascular Disease
Bhake, R. C., Chittake, V., Lumpatki, S. B., Tiwari, S., & Unnikrishnan, A. G. (2025) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_12_25 · Cited by 3
Iino, C., Mikami, K., Furusawa, K., Sato, S., Yoshida, K., Yamaguchi, T., Bushita, H., Kinoshita, K., Matsui, Y., Imoto, S., et al. (2026) · Nutrients · doi:10.3390/nu18050851 · Cited by 2
Laichuthai, N., & DeFronzo, R. A. (2021) · Journal of Endocrinological Science · doi:10.29245/2767-5157/2021/1.1115 · Cited by 3
Ahmed, H., Mohamed, S. G., Ibrahim, W. S., Rezk, A. M., Mahmoud, A. A. A., Mahmoud, M. F., & Ibrahim, I. A. A. E.-H. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0299 · Cited by 2
Honarkar-Shafie, E., Hosseinzadeh‐Attar, M. J., Taheri, F., Moosavi, N., Yaseri, M., Alidoosti, M., & Vasheghani‐Farahani, A. (2023) · The Journal of Tehran University Heart Center · doi:10.18502/jthc.v18i1.12574 · Cited by 4
Metadata
- Authors
- Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Gast, Karin B.
- Tjeerdema, Nathanja
- Stijnen, Theo
- Smit, Johannes W. A.
- Dekkers, Olaf M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-28
- Volume
- 7
- Issue
- 12
- Pages
- e52036
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3532497
- OpenAlex
- W2039758398
- Cited by
- 403
- References
- 33
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 60 · 2023: 50 · 2022: 52 · 2021: 40 · 2020: 35 · 2019: 26 · 2018: 17 · 2017: 15 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Universiteit Leiden
- Leids Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, HOMA-IR, fasting blood glucose, fasting insulin, incident cardiovascular disease, coronary artery disease, stroke, cardiovascular risk prediction, non-diabetic adults, risk stratification model, risk reclassification, risk prediction thresholds
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.